<DOC>
	<DOC>NCT02392156</DOC>
	<brief_summary>The primary objective of the study is to evaluate the effectiveness of prophylactic treatment with recombinant Factor VIII Fc fusion protein (rFVIIIFc) and recombinant Factor IX Fc fusion protein (rFIXFc) therapy as assessed by patient treatment burden and health economic outcomes while maintaining disease control in males with hemophilia A or B.</brief_summary>
	<brief_title>Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Key Have a medically documented diagnosis of hemophilia A or B that is being treated prophylactically with a factor replacement product not designed to have a prolonged halflife and satisfy a therapeutic indication for rFVIIIFc/rFIXFc per the approved local label Have at least 50 prior exposure days (EDs) to any combination of factor replacement products Have documented prestudy data available that confirm fulfillment of the eligibility criteria Have no measurable inhibitor activity in a sample obtained within 4 weeks prior to the Baseline visit, and absence of clinical signs or symptoms of decreased response to the current factor replacement product Key Have a diagnosis of any bleeding disorder other than hemophilia A or hemophilia B or an additional coagulation disorder(s) in addition to hemophilia A or hemophilia B Have a prior history of anaphylaxis associated with any factor VIII (FVIII)/ factor IX (FIX) or intravenous immunoglobin administration Had an inhibitor within 5 years before the Baseline visit. Note: A family history of inhibitors will not exclude the patient. Past or current treatment with any factor replacement product with a prolonged halflife, including an Fc product, for the treatment of hemophilia NOTE: Other Protocol Defined Inclusion/ Exclusion Criteria May Apply.</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>